HF
NERV icon

HRT Financial’s Minerva Neurosciences NERV Stock Holding History

HRT Financial’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-12,368
Closed -$229K – 3607
2021
Q2 		$229K Buy
+12,368
New +$266K ﹤0.01% 2312
2020
Q1 		– Sell
-9,099
Closed -$517K – 1156
2019
Q4 		$517K Buy
+9,099
New +$401K 0.02% 519

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HRT Financial's NERV Position: Q3 2021 in Review

HRT Financial sold out of Minerva Neurosciences (NERV) in Q3 2021, closing a stake of 12,368 shares — an estimated $229K sold.

HRT Financial first reported a position in NERV in Q4 2019 and held it in 2 quarters. The position peaked at $517K in Q4 2019. 46 funds tracked by Wall St. Rank hold NERV as of Q3 2021.

  • HRT Financial reported no remaining Minerva Neurosciences position as of Q3 2021 after selling out during the quarter.
  • HRT Financial sold 12,368 Minerva Neurosciences shares in Q3 2021, an estimated $229K.
  • HRT Financial first reported a position in Minerva Neurosciences in Q4 2019 and held it in 2 quarters.
  • HRT Financial's Minerva Neurosciences position peaked at $517K in Q4 2019.
  • 46 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q3 2021.

Based on HRT Financial's 13F filing for Q3 2021, filed 15 Nov 2021.